## SECTION I - STUDY RELEVANCE & APPLICABILITY

## SECTION I - STUDY RELEVANCE & APPLICABILITY

### 1. Decision Context & Population

| Item | Assessment Criterion                                                                                                                      | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ----------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 1.1  | **Target Population Definition**: Is the target patient population for decision-making clearly and specifically defined?                  | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 1.2  | **Population Applicability**: Are the NMA results applicable to the population/setting of interest to the decision maker?                 | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 1.3  | **Demographic Alignment**: Do trial populations match the target demographic characteristics (age, sex, disease severity, comorbidities)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 1.4  | **Geographic/Healthcare Context**: Is the healthcare setting (country, care level, reimbursement context) relevant?                       | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 2. Interventions & Comparators

| Item | Assessment Criterion                                                                                                            | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 2.1  | **Decision Comparator Set**: Have all appropriate treatments in the decision been identified?                                   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 2.2  | **Synthesis Comparator Set**: If additional treatments are included beyond the decision set, is this adequately justified?      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 2.3  | **Treatment Definition Specificity**: Are treatments restricted to specific doses, schedules, and co-treatments (not "lumped")? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 2.4  | **Dose Justification**: If different doses/formulations are pooled, is this clinically and statistically justified?             | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 2.5  | **Standard of Care Alignment**: Do comparators reflect current clinical practice and available alternatives?                    | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 3. Outcomes

| Item | Assessment Criterion                                                                                   | Rating                                                                                                                                              | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 3.1  | **Outcome Relevance**: Are the outcomes examined important to patients and decision makers?            | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 3.2  | **Outcome Timeframe**: Are follow-up periods clinically meaningful and consistent with decision needs? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 3.3  | **Outcome Definition**: Are outcome definitions consistent across studies or appropriately harmonized? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

---
